29 studies found for:    neurology AND university AND San Francisco | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Brain Development Research Program
Conditions: Brain Disorders;   Aicardi Syndrome
Intervention:
2 Recruiting Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
Condition: Cryptogenic Sensory Polyneuropathy
Interventions: Drug: Nortriptyline;   Drug: Duloxetine;   Drug: Pregabalin;   Drug: Mexiletine
3 Recruiting Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Condition: Pediatric Multiple Sclerosis
Intervention:
4 Recruiting A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
Conditions: Dravet Syndrome;   Seizure Disorder
Interventions: Drug: ZX008 (Fenfluramine Hydrochloride);   Drug: Matching Placebo
5 Recruiting Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Condition: Carotid Stenosis
Interventions: Procedure: Carotid endarterectomy;   Device: Carotid stenting
6 Recruiting Study of Urate Elevation in Parkinson's Disease, Phase 3
Condition: Parkinson's Disease
Interventions: Drug: Inosine;   Drug: Placebo
7 Recruiting Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition: Huntington's Disease
Intervention:
8 Recruiting Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Conditions: Transthyretin Mutations;   Transthyretin Amyloidosis
Intervention: Other: None. Observational Study.
9 Recruiting Pediatric Open-Label Extension Study
Conditions: Schizophrenia;   Autism;   Bipolar Depression
Intervention: Drug: Lurasidone 20, 40, 60, 80 mg, flexibly dosed
10 Recruiting Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Condition: Familial Frontotemporal Dementia
Intervention:
11 Recruiting A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia
Condition: Alzheimer's Disease
Interventions: Drug: LY3314814;   Drug: Placebo
12 Recruiting An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease
Condition: Alzheimer´s Disease
Interventions: Drug: LY3314814;   Drug: Placebo
13 Recruiting Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: other disease-modifying therapy
14 Recruiting The Human Epilepsy Project
Condition: Focal Epilepsy
Intervention:
15 Recruiting A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Conditions: Menopause;   Multiple Sclerosis
Interventions: Drug: Tissue Selective Estrogen Complex;   Drug: Placebo
16 Recruiting SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
Condition: Alzheimer's Disease
Interventions: Drug: SUVN-502;   Drug: Placebo
17 Recruiting A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Condition: Alzheimer's Disease
Interventions: Drug: LY3202626;   Drug: Placebo
18 Recruiting Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Condition: Cognition Disorders
Interventions: Drug: Solanezumab;   Drug: Placebo
19 Recruiting Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Condition: Stroke
Interventions: Drug: GM602;   Drug: Placebo Comparator
20 Recruiting A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
Condition: Glioblastoma
Interventions: Drug: VB-111 + bevacizumab;   Drug: Bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years